Clinical Trials Directory

Trials / Completed

CompletedNCT03835364

Aptus at Home: Co-design of a Home-based Monitoring System for Anaemia

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Entia Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Co-design of a home-based anaemia monitoring system with participants who have previous diagnosis of anaemia.

Detailed description

The device/ monitoring system being developed is called Aptus home. Aptus home measures the haemoglobin and haematocrit levels in blood from a single drop of blood. By measuring these blood parameters, participants are able to monitor anaemia in participants' homes. The use of the device will take place in the participant's home to simulate what the investigators believe will be the ideal location for people who would prefer to self-manage their condition. This study is a unique opportunity to gain feedback on the future design and development of a home-based monitoring system through user evaluation. As this is an adaptive/ iterative study design, this will give the Sponsor the opportunity to make changes to the user interface and user platform based on the feedback received from the end user.

Conditions

Interventions

TypeNameDescription
DEVICEBlood measurementSingle fingerprick to measure haemoglobin and haematocrit measurements using the Aptus Home, anaemia home monitoring system.

Timeline

Start date
2018-04-13
Primary completion
2021-01-15
Completion
2021-01-15
First posted
2019-02-08
Last updated
2021-02-09

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03835364. Inclusion in this directory is not an endorsement.